← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:938 | 938 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-312 | 70092-312-75 | Midazolam Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:938 | 938 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:938 | 938 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6610 | 71300-6610-3 | Naltrexone Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:938 | 938 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2307 | 72934-2307-2 | Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:938 | 938 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2567 | 72934-2567-2 | Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:938 | 938 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:938 | 938 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5183 | 26436-5183-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:939 | 939 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-010 | 71170-010-10 | Phenylephrine HCl 1 mg per 10 mL Syringe (100 mcg/mL) | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:939 | 939 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:939 | 939 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:939 | 939 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1118 | 5446-1118-01 | Lidocaine; Phenylephrine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:939 | 939 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5243 | 26436-5243-1 | Liothyronine Sodium | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:939 | 939 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:939 | 939 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:939 | 939 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate Anhydrous | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:939 | 939 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1020 | 73013-1020-1 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:939 | 939 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-177 | 70092-177-35 | Midazolam Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:939 | 939 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:939 | 939 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6610 | 71300-6610-9 | Naltrexone Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:939 | 939 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2308 | 72934-2308-2 | Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:939 | 939 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2568 | 72934-2568-2 | Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:939 | 939 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:939 | 939 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5112 | 26436-5112-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:940 | 940 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-957 | 69374-957-10 | Phenylephrine Hydrochloride 100mcg/mL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:940 | 940 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:940 | 940 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:940 | 940 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1045 | 5446-1045-03 | Lidocaine; Phenylephrine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:940 | 940 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5436 | 26436-5436-1 | Liothyronine Sodium | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:940 | 940 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-066 | 71506-066-10 | Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:940 | 940 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:940 | 940 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate Anhydrous | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:940 | 940 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-613 | 70092-613-79 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:940 | 940 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-032 | 70092-032-50 | Midazolam Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:940 | 940 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5354 | 26436-5354-1 | Methylene Blue | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:940 | 940 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6647 | 71300-6647-3 | Naltrexone Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:940 | 940 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2429 | 72934-2429-2 | Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:940 | 940 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-144 | 73702-144-60 | Nicotinamide Riboside Chloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:940 | 940 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6044 | 72196-6044-1 | Oxytocin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:940 | 940 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5137 | 26436-5137-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:941 | 941 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9018 | 83826-9018-5 | Timolol, Bimatoprost | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:941 | 941 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:941 | 941 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:941 | 941 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0790 | 5446-0790-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:941 | 941 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lomustine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:941 | 941 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-043 | 71506-043-01 | Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:941 | 941 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:941 | 941 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate Anhydrous | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:941 | 941 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:941 | 941 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4036 | 71286-4036-1 | Midazolam Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:941 | 941 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-5 | Methylprednisolone Acetate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:941 | 941 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6647 | 71300-6647-9 | Naltrexone Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:941 | 941 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2299 | 72934-2299-4 | Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:941 | 941 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-146 | 73702-146-61 | Nicotinamide Riboside Chloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:941 | 941 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5103 | 71266-5103-1 | Oxytocin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:941 | 941 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-027 | 73198-027-03 | Papaverine Hydrochloride; Phentolamine Mesylate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:942 | 942 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-009 | 73198-009-03 | NB-243 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:942 | 942 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:942 | 942 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:942 | 942 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0407 | 5446-0407-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:942 | 942 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lomustine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:942 | 942 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-041 | 71506-041-05 | Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:942 | 942 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:942 | 942 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-097 | 71449-097-42 | Moxifloxacin Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:942 | 942 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:942 | 942 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-2 | Midazolam Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:942 | 942 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-3 | Methylprednisolone Acetate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:942 | 942 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6600 | 71300-6600-3 | Naltrexone Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:942 | 942 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1304 | 72934-1304-2 | Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:942 | 942 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-133 | 73702-133-02 | Norepinephrine | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:942 | 942 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:942 | 942 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-027 | 73198-027-10 | Papaverine Hydrochloride; Phentolamine Mesylate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:943 | 943 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5027 | 26436-5027-2 | Alpha Lipoic acid | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:943 | 943 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:943 | 943 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:943 | 943 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1018 | 5446-1018-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:943 | 943 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lomustine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:943 | 943 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:943 | 943 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:943 | 943 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-096 | 71449-096-42 | Moxifloxacin Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:943 | 943 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:943 | 943 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-3 | Midazolam Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:943 | 943 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:943 | 943 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6600 | 71300-6600-9 | Naltrexone Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:943 | 943 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2300 | 72934-2300-2 | Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:943 | 943 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-550 | 71170-550-25 | Norepinephrine | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:943 | 943 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:943 | 943 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-012 | 73198-012-05 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:944 | 944 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1579 | 72934-1579-2 | Artilis | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:944 | 944 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:944 | 944 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:944 | 944 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0408 | 5446-0408-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:944 | 944 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lomustine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:944 | 944 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:944 | 944 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:944 | 944 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:944 | 944 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:944 | 944 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-418 | 70092-418-36 | Midazolam Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:944 | 944 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:944 | 944 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6646 | 71300-6646-9 | Naltrexone Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:944 | 944 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-146 | 73702-146-61 | Nicotinamide Riboside Chloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:944 | 944 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-027 | 71506-027-58 | Norepinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:944 | 944 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:944 | 944 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-012 | 73198-012-03 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:945 | 945 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5617 | 72934-5617-8 | Divinix | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:945 | 945 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:945 | 945 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:945 | 945 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-2114 | 73271-2114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:945 | 945 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lomustine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:945 | 945 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6006 | 71286-6006-1 | Lidocaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:945 | 945 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Prilocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:945 | 945 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:945 | 945 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2467 | 72907-2467-1 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:945 | 945 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-030 | 70092-030-36 | Midazolam Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:945 | 945 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:945 | 945 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6646 | 71300-6646-3 | Naltrexone Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:945 | 945 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-144 | 73702-144-60 | Nicotinamide Riboside Chloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:945 | 945 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5016 | 71266-5016-2 | Norepinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:945 | 945 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:945 | 945 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-012 | 73198-012-10 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:946 | 946 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-1087 | 79559-1087-1 | S-T087.5 | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:946 | 946 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:946 | 946 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:946 | 946 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-5114 | 73271-5114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:946 | 946 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-048 | 70713-048-03 | Lysine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:946 | 946 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:946 | 946 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Prilocaine Hydrochloride; Gabapentin | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:946 | 946 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8602 | 71266-8602-1 | Moxifloxacin Hydrochloride | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:946 | 946 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-380 | 70092-380-36 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:946 | 946 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-411 | 70004-411-59 | Midazolam Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:946 | 946 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:946 | 946 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:946 | 946 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-550 | 71170-550-25 | Norepinephrine | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:946 | 946 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5026 | 71266-5026-2 | Norepinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:946 | 946 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:946 | 946 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-015 | 73198-015-03 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:947 | 947 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-151 | 69194-151-01 | 151 CALCIUM GLUCONATE 2.5% JAR | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:947 | 947 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:947 | 947 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:947 | 947 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-6114 | 73271-6114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:947 | 947 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0401 | 72196-0401-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:947 | 947 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:947 | 947 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0217 | 72196-0217-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Calcium Chloride; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Dextrose Monohydrate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:947 | 947 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:947 | 947 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-518 | 70092-518-75 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:947 | 947 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:947 | 947 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1075 | 71266-1075-1 | Methylprednisolone Acetate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:947 | 947 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5614 | 26436-5614-1 | Naltrexone Hydrochloride Dihydrate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:947 | 947 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5040 | 70214-5040-1 | Norepinephrine | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:947 | 947 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5021 | 71266-5021-2 | Norepinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:947 | 947 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:947 | 947 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-015 | 73198-015-10 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:948 | 948 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6508 | 72934-6508-2 | Mavilo | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:948 | 948 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:948 | 948 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:948 | 948 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1114 | 73271-1114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:948 | 948 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0401 | 71285-0401-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:948 | 948 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:948 | 948 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0211 | 71285-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:948 | 948 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:948 | 948 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6795 | 60652-6795-2 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:948 | 948 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:948 | 948 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-1 | Midazolam | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:948 | 948 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5615 | 26436-5615-1 | Naltrexone Hydrochloride Dihydrate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:948 | 948 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-027 | 71506-027-58 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:948 | 948 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-032 | 71506-032-58 | Norepinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:948 | 948 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:948 | 948 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-019 | 73198-019-05 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:949 | 949 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-523 | 70092-523-50 | Morphine PF 1 mg/ml 50 ml NS syr | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:949 | 949 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:949 | 949 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0211 | 72196-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:949 | 949 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-3114 | 73271-3114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:949 | 949 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0422 | 72196-0422-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:949 | 949 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:949 | 949 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0211 | 72196-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:949 | 949 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:949 | 949 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-979 | 69374-979-02 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:949 | 949 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-103 | 81375-103-40 | Mitomycin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:949 | 949 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-2 | Midazolam | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:949 | 949 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5610 | 26436-5610-1 | Naltrexone Hydrochloride Dihydrate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:949 | 949 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-117 | 69194-117-10 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:949 | 949 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:949 | 949 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:949 | 949 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-019 | 73198-019-03 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:950 | 950 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-2243 | 72682-2243-1 | Ascorbic Acid (PF/Non-Corn) 500 mg/ml 10mL Refrig | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:950 | 950 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:950 | 950 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0211 | 71285-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:950 | 950 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-7114 | 73271-7114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:950 | 950 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0415 | 72196-0415-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:950 | 950 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:950 | 950 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6622 | 71300-6622-5 | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:950 | 950 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Triamcinolone Acetonide | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:950 | 950 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-979 | 69374-979-30 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:950 | 950 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-100 | 81375-100-40 | Mitomycin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:950 | 950 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-04 | Midazolam | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:950 | 950 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5611 | 26436-5611-1 | Naltrexone Hydrochloride Dihydrate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:950 | 950 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:950 | 950 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5025 | 71266-5025-2 | Norepinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:950 | 950 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-028 | 71506-028-59 | Oxytocin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:950 | 950 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-018 | 73198-018-05 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:951 | 951 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0043 | 81483-0043-5 | ADRENALIN | 2026-1 | valid | 0 | 2026-09-18 |